Long-acting Benzodiazepines
- Lorazepam
- Diazepam
- Clonazepam
- Chlordiazepoxide
- Insomnia
- Anxiety
- Seizures
- Eclampsia
- Alcohol Withdrawal
- Half-life > 24 Hours
- Dependence
Substance Use Disorder
- 2 or More Symptoms For 1 year
- Tolerance
- Withdrawal Symptoms
- Cravings
- Using More Than Intended
- Inability to Cut Down
- Time-Consuming Substance Acquisition
- Impaired Functioning at Work
- Reduced Recreational Activities
- Dangerous Activities
- Continued Use
Substance Use Disorder Assessment (Formerly Substance Abuse Assessment)
- Changes in Mood
- Poor Hygiene
- Odd Sleep Patterns
- Frequent Injuries
- Relationship or Job Difficulty
- Poor Performance
- Anorexia OR Weight Loss
- Social Isolation
- Financial Problems
Opioid Use Disorder and Withdrawal Assessment (Formerly Opioid Abuse and Withdrawal Assessment)
- Euphoria
- Miosis
- CNS Depression
- Yawning
- Gooseflesh
- Sweating
- Rhinorrhea
- Kicking Movements
- Naloxone
Opioids Overview
- Pain
- Weaning
- Cough
- Diarrhea
- Agonists at Mu (μ), Kappa (Κ), and Delta (δ) Receptors
- Decrease Synaptic Transmission
- Respiratory Depression
- Addiction
- Miosis
- Constipation
Naloxone (Narcan)
- Competitive Opioid Receptor Antagonist
- Opioid Induced CNS Depression
- Severe Nausea and Vomiting
- Excitable State
- Opioid Withdrawal Symptoms
- Repeated Dosing Often Required
Buprenorphine-Naloxone (Suboxone)
- Combination Drug
- Partial Opioid Receptor Agonist (Buprenorphine)
- Opioid Receptor Antagonist (Naloxone)
- Opioid Use Disorder
- CNS Depression
- Diaphoresis
- Hypotension
- Low Abuse Potential
Codeine
- Opioid Receptor Agonist
- Mild to Moderate Pain
- Cough Suppressant
- Sedation
- Constipation
- Miosis
- Close Monitoring When Breast Feeding
- Often Combined with Non-Opioids
Tramadol
- Chronic Pain
- Weak Opioid
- Inhibit Serotonin and NE reuptake
- Increased Risk of Seizure
Oxycodone
- Opioid Receptor Agonist
- Refractory Pain
- Respiratory Depression
- Constipation
- CNS Depression
- Addiction
- Naloxone
Morphine
- Opioid Receptor Agonist
- Pain
- Myocardial Infarction
- Nausea and Vomiting
- CNS Depression
- Biliary Colic
- Constipation
- Increased Intracranial Pressure (ICP)
- Pupillary Constriction
- Hypotension
Fentanyl
- Opioid Receptor Agonist
- High Potency
- Anesthesia Induction
- Chronic Pain
- Breakthrough Pain
- CNS Depression
- Respiratory Depression
- Constipation
- Miosis
- Addiction
Alcohol Use Disorder Assessment (Formerly Alcohol Abuse Assessment)
- CNS Depression
- Wernicke-Korsakoff Syndrome
- GI Distress
- Cardiomyopathy
- Pancreatitis
- Cirrhosis
- Immunosuppression
- Sexual Dysfunction
- Screening (Assessments)
Wernicke-Korsakoff Syndrome
- Thiamine deficiency
- Confusion
- Ophthalmoplegia
- Ataxia
- Korsakoff
- Confabulation
- Personality Changes
- Memory loss
- Alcoholics
- Damage to medial dorsal nucleus
- Damage to mammillary bodies
Alcohol Use Disorder Interventions (Formerly Alcohol Abuse Interventions)
- Reduce Environmental Stimuli
- Antianxiety Medications
- Vitamin Supplements
- Seizure Precautions
- Suicide Precautions
- Fever
- Identify Support Systems
- Group Therapy
- Disulfiram
- Naltrexone
Amphetamines Intoxication Assessment
- Euphoria
- Insomnia
- Mydriasis
- Diaphoresis
- Hypertension
- Tachycardia
- Paranoia
- Anxiety
- Anorexia
- Seizures
Amphetamine Antidote
- Ammonium Chloride (NH4Cl)
- Acidify Urine
Cocaine Intoxication Assessment
- Euphoria
- Delusions
- Mydriasis
- Hallucinations
- Agitation
- Hypertension
- Arrhythmias
- Hyperthermia
- Seizures
- Nasal Septum Perforation
Phencyclidine (PCP) Intoxication Assessment
- Violent Behavior
- Motor Issues
- Nystagmus
- Increased Pain Tolerance
- Tachycardia
- Delirium
- Seizures
- Psychosis
LSD Intoxication Assessment
- Psychosis
- Perceptual Distortion
- Visual Hallucinations
- Paranoia
- Depersonalization
- Anxiety
- Tachycardia
- Flashbacks
Marijuana Intoxication Assessment
- Euphoria
- Slowed Reaction Time
- Conjunctival Injection
- Increased Appetite
- Anxiety
- Social Withdrawal
- Paranoid Delusions
Barbiturates
- Barb- Drug Names
- Seizure Treatment
- Anesthesia Induction
- Increased Duration of Cl- Channel Opening
- Decrease Neuron Firing
- Sedation
- Cardiovascular and Respiratory Depression
- CNS Depression
- P450 inducer
Phenobarbital (Barbiturates)
- Barbiturate
- Seizures
- Ataxia
- Paradoxical Excitement
- Fatigue/Drowsiness
- Monitor Plasma Levels
- High Potential for Abuse
Benzodiazepine Intoxication Assessment
- Drowsiness
- Confusion
- Respiratory Depression
- Hypotension
- Coma
- Flumazenil (Romazicon)
Benzodiazepines Overview
- First Line for Status Epilepticus
- Anesthesia Induction
- Anxiety
- Eclampsia
- Detoxification
- '-zepam' and '-zolam" Suffix
- Increase Frequency of Cl- Channel Opening
- Decrease REM Sleep
- CNS Depression
- Dependence
- Flumazenil for Overdose
Short-acting Benzodiazepines
- ATOM
- Alprazolam
- Triazolam
- Oxazepam
- Midazolam
- Anesthesia Induction
- Insomnia
- Anxiety
- Half-life < 12 Hours
- Dependence
CNS Stimulants
- Attention Deficit Hyperactivity Disorder (ADHD)
- Obesity
- Increase Catecholamines at Synaptic Cleft
- Increase Norepinephrine
- Increase Dopamine
- Methylphenidate (Ritalin)
- Methamphetamine
- Potential for Abuse
CNS Stimulant Indications
- Amphetamine
- Methylphenidate (Ritalin)
- Increased Norepinephrine
- Increased Dopamine
- Attention Deficit Hyperactivity Disorder (ADHD)
- Obesity
- Narcolepsy
CNS Stimulant Side Effects
- Agitation
- Insomnia
- Hypertension
- Tachycardia
- Tics
- Anorexia
- Tolerance Develops
- High Risk of Abuse and Dependence